Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medtronic plc Director's Dealing 2018

Sep 25, 2018

29841_dirs_2018-09-25_2fb836eb-4086-40f3-aa7e-1c421303f18a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2018-09-24

Reporting Person: Martha Geoffrey (EVP & GroupPres Restora Therap)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-09-24 Ordinary Shares M 28670 $34.88 Acquired 87872 Direct
2018-09-24 Ordinary Shares M 21129 $38.81 Acquired 109001 Direct
2018-09-24 Ordinary Shares S 49799 $97.927 Disposed 59202 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-09-24 Stock Option (Right to Buy) $34.88 M 28670 Disposed 2021-08-01 Ordinary Shares (28670) Direct
2018-09-24 Stock Option (Right to Buy) $38.81 M 21129 Disposed 2022-07-30 Ordinary Shares (21129) Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $97.911 to $97.965, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2: This option to purchase 28,670 ordinary shares of New Medtronic for $34.88 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 28,670 Medtronic common stock shares for $34.88 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

F3: This option to purchase 21,129 New Medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 21,129 Medtronic common stock shares for $38.81 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.